Wholesaler Hike Drives UK Price Spike In February
Pricewatch UK – February 2023
Increases by one particular wholesaler led to steep rises for a number of UK generics in February, according to market researcher WaveData.
You may also be interested in...
Two products featured highly among the fastest-rising UK generics prices in March, but for different reasons.
Partners Apotex and Ambio have announced approval of a second US teriparatide generic from the FDA, adding another Forteo rival to the market and removing hopes that Teva’s recently approved first generic could benefit from 180 days of market exclusivity. Further competition is also in the works with Amphastar awaiting FDA action on a further teriparatide ANDA.
Partners Fresenius Kabi and Formycon have submitted a US filing for their FYB202 ustekinumab biosimilar rival to Stelara.